National Planning Corporation’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-2,543
Closed -$212K 708
2016
Q2
$212K Buy
+2,543
New +$181K 0.02% 590
2016
Q1
Sell
-6,182
Closed -$317K 754
2015
Q4
$317K Buy
+6,182
New +$390K 0.03% 501
2015
Q3
Sell
-2,947
Closed -$211K 680
2015
Q2
$211K Buy
+2,947
New +$213K 0.02% 567
2015
Q1
Sell
-7,393
Closed -$487K 2510
2014
Q4
$487K Sell
7,393
-7,653
-51% -$493K 0.03% 410
2014
Q3
$930K Buy
15,046
+1,477
+11% +$96.5K 0.07% 261
2014
Q2
$940K Buy
13,569
+614
+5% +$39.8K 0.07% 258
2014
Q1
$858K Buy
12,955
+6,400
+98% +$417K 0.07% 263
2013
Q4
$404K Buy
6,555
+1,350
+26% +$78.2K 0.04% 424
2013
Q3
$281K Buy
+5,205
New +$268K 0.03% 508

Other funds holding STJ

National Planning Corporation's STJ Position: Q3 2016 in Review

National Planning Corporation sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 2,543 shares — an estimated $212K sold.

National Planning Corporation first reported a position in STJ in Q3 2013 and held it in 9 quarters. The position peaked at $940K in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • National Planning Corporation reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • National Planning Corporation sold 2,543 St Jude Medical shares in Q3 2016, an estimated $212K.
  • National Planning Corporation first reported a position in St Jude Medical in Q3 2013 and held it in 9 quarters.
  • National Planning Corporation's St Jude Medical position peaked at $940K in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on National Planning Corporation's 13F filing for Q3 2016, filed 10 Nov 2016.